These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35128348)

  • 21. INeo-Epp: A Novel T-Cell HLA Class-I Immunogenicity or Neoantigenic Epitope Prediction Method Based on Sequence-Related Amino Acid Features.
    Wang G; Wan H; Jian X; Li Y; Ouyang J; Tan X; Zhao Y; Lin Y; Xie L
    Biomed Res Int; 2020; 2020():5798356. PubMed ID: 32626747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions.
    Larsen MV; Lundegaard C; Lamberth K; Buus S; Brunak S; Lund O; Nielsen M
    Eur J Immunol; 2005 Aug; 35(8):2295-303. PubMed ID: 15997466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of HLA ligand elution data and binding predictions reveals varying prediction performance for the multiple motifs recognized by HLA-DQ2.5.
    Koşaloğlu-Yalçın Z; Sidney J; Chronister W; Peters B; Sette A
    Immunology; 2021 Feb; 162(2):235-247. PubMed ID: 33064841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
    Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
    PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction.
    Larsen MV; Lundegaard C; Lamberth K; Buus S; Lund O; Nielsen M
    BMC Bioinformatics; 2007 Oct; 8():424. PubMed ID: 17973982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene and protein sequence features augment HLA class I ligand predictions.
    Bresser K; Nicolet BP; Jeko A; Wu W; Loayza-Puch F; Agami R; Heck AJR; Wolkers MC; Schumacher TN
    Cell Rep; 2024 Jun; 43(6):114325. PubMed ID: 38870014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection.
    Rozanov DV; Rozanov ND; Chiotti KE; Reddy A; Wilmarth PA; David LL; Cha SW; Woo S; Pevzner P; Bafna V; Burrows GG; Rantala JK; Levin T; Anur P; Johnson-Camacho K; Tabatabaei S; Munson DJ; Bruno TC; Slansky JE; Kappler JW; Hirano N; Boegel S; Fox BA; Egelston C; Simons DL; Jimenez G; Lee PP; Gray JW; Spellman PT
    J Proteomics; 2018 Mar; 176():13-23. PubMed ID: 29331515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and Screening of an Antigen-Derived Peptide Library Displayed on Yeast Cell Surface for CD4+ T Cell Epitope Identification.
    Wen F; Smith MR; Zhao H
    Methods Mol Biol; 2019; 2024():213-234. PubMed ID: 31364052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of binding specificities of bovine leucocyte class I molecules: impacts for rational epitope discovery.
    Hansen AM; Rasmussen M; Svitek N; Harndahl M; Golde WT; Barlow J; Nene V; Buus S; Nielsen M
    Immunogenetics; 2014 Dec; 66(12):705-18. PubMed ID: 25186069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides.
    Besser H; Yunger S; Merhavi-Shoham E; Cohen CJ; Louzoun Y
    J Immunother Cancer; 2019 May; 7(1):135. PubMed ID: 31118084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity.
    Oyarzún P; Ellis JJ; Bodén M; Kobe B
    BMC Bioinformatics; 2013 Feb; 14():52. PubMed ID: 23409948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes.
    Jørgensen KW; Buus S; Nielsen M
    PLoS One; 2010 Dec; 5(12):e15877. PubMed ID: 21209859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+ T-cell epitope prediction using antigen processing constraints.
    Mettu RR; Charles T; Landry SJ
    J Immunol Methods; 2016 May; 432():72-81. PubMed ID: 26891811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved methods for predicting peptide binding affinity to MHC class II molecules.
    Jensen KK; Andreatta M; Marcatili P; Buus S; Greenbaum JA; Yan Z; Sette A; Peters B; Nielsen M
    Immunology; 2018 Jul; 154(3):394-406. PubMed ID: 29315598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Customized predictions of peptide-MHC binding and T-cell epitopes using EPIMHC.
    Molero-Abraham M; Lafuente EM; Reche P
    Methods Mol Biol; 2014; 1184():319-32. PubMed ID: 25048133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicted MHC peptide binding promiscuity explains MHC class I 'hotspots' of antigen presentation defined by mass spectrometry eluted ligand data.
    Jappe EC; Kringelum J; Trolle T; Nielsen M
    Immunology; 2018 Jul; 154(3):407-417. PubMed ID: 29446062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combination of epitope prediction and molecular docking allows for good identification of MHC class I restricted T-cell epitopes.
    Zhang XW
    Comput Biol Chem; 2013 Aug; 45():30-5. PubMed ID: 23666426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods.
    Zhang H; Lundegaard C; Nielsen M
    Bioinformatics; 2009 Jan; 25(1):83-9. PubMed ID: 18996943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemplating immunopeptidomes to better predict them.
    Gfeller D; Liu Y; Racle J
    Semin Immunol; 2023 Mar; 66():101708. PubMed ID: 36621290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated modeling of the major events in the MHC class I antigen processing pathway.
    Dönnes P; Kohlbacher O
    Protein Sci; 2005 Aug; 14(8):2132-40. PubMed ID: 15987883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.